Abiopharma

Kyrillos Jean-Claude 🟡 adjusted position in 2.1K shares (1 derivative) of TANDEM DIABETES CARE INC (TNDM) at $21.07 Transaction Date: Jan 15, 2026 | Filing ID: 000003

Halozyme - Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update

Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

New Form 3 - Trinseo PLC Filed: 2026-01-20 AccNo: 0001798190-26-000002 Size: 9 KB

New Form 3 - Trinseo PLC Filed: 2026-01-20 AccNo: 0001775666-26-000003 Size: 9 KB

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Forbes William P 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016451

Duarte Ira 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016423

New Form SCHEDULE 13G/A - PetVivo Holdings, Inc. Filed: 2026-01-20 AccNo: 0001291984-26-000001 Size: 6 KB

Collard Craig A 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016413

Agilon Health Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)